BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee HJ, Lee DG, Choi SM, Park SH, Cho SY, Choi JK, Kim SH, Choi JH, Yoo JH, Cho BS, Eom KS, Lee S, Kim YJ, Kim HJ, Min CK, Kim DW, Lee JW, Min WS, Jung JI. The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population. PLoS One 2017;12:e0173250. [PMID: 28278166 DOI: 10.1371/journal.pone.0173250] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Taha R, Kothari S, Foroutan F, Gitman M, Gupta V, Nguyen T, Rotstein C. Implementation of a Routine Screening Program for Latent Tuberculosis Infection among Patients with Acute Leukemia at a Canadian Cancer Center. Curr Oncol 2022;29:9325-34. [PMID: 36547145 DOI: 10.3390/curroncol29120731] [Reference Citation Analysis]
2 Schaberg T, Brinkmann F, Feiterna-sperling C, Geerdes-fenge H, Hartmann P, Häcker B, Hauer B, Haas W, Heyckendorf J, Lange C, Maurer FP, Nienhaus A, Otto-knapp R, Priwitzer M, Richter E, Salzer HJ, Schoch O, Schönfeld N, Stahlmann R, Bauer T. Tuberkulose im Erwachsenenalter. Pneumologie 2022;76:727-819. [DOI: 10.1055/a-1934-8303] [Reference Citation Analysis]
3 Lip A, Karsanji D, Grossman J, Field S. Successful hematopoietic stem cell transplantation for acute myelomonocytic leukemia in a patient with active pulmonary tuberculosis. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022;6:275-278. [DOI: 10.1080/24745332.2021.1955038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bergeron A. Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions! Bone Marrow Transplant 2021;56:2050-1. [PMID: 34145415 DOI: 10.1038/s41409-021-01381-z] [Reference Citation Analysis]
5 Kapoor J, Mirgh SP, Khushoo V, Mehta P, Ahmed R, Bansal N, Bhurani D, Agrawal N. Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it out. Ther Adv Infect Dis 2021;8:20499361211008674. [PMID: 33912346 DOI: 10.1177/20499361211008674] [Reference Citation Analysis]
6 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2021. [DOI: 10.1007/978-3-030-25869-6_15] [Reference Citation Analysis]
7 Munoz FM, Ling Lin P. Nontuberculous and tuberculous Mycobacterium. Pediatric Transplant and Oncology Infectious Diseases 2021. [DOI: 10.1016/b978-0-323-64198-2.00025-7] [Reference Citation Analysis]
8 Sosa-Moreno A, Narita M, Spitters C, Swetky M, Podczervinski S, Lind ML, Holmberg L, Liu C, Edelstein R, Pergam SA. A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients. Open Forum Infect Dis 2020;7:ofaa224. [PMID: 32671130 DOI: 10.1093/ofid/ofaa224] [Reference Citation Analysis]
9 Konuma T, Isobe M, Adachi E, Kato S, Takahashi S, Yotsuyanagi H, Tojo A. Disseminated Tuberculosis with Cholecystitis in a Patient after Cord Blood Transplantation. Intern Med 2020;59:2769-71. [PMID: 32669496 DOI: 10.2169/internalmedicine.4923-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Zeng Q, Zhang Y, Wu Y, Zhang Z, Zhang J, Fu H, Wang J, Wang F, Yan C, Mo X, Wang Y, Chen Y, Chang Y, Xu L, Liu K, Huang X, Zhang X. Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2020;26:1203-9. [DOI: 10.1016/j.bbmt.2020.02.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
11 Malhotra P, Gautam-goyal P, Epstein ME. Renal infections in cancer patients. Onco-Nephrology 2020. [DOI: 10.1016/b978-0-323-54945-5.00045-x] [Reference Citation Analysis]
12 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2020. [DOI: 10.1007/978-3-030-01751-4_15-1] [Reference Citation Analysis]
13 Yang A, Shi J, Luo Y, Ye Y, Tan Y, Huang H, Zhao Y. Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis. Sci Rep 2019;9:20402. [PMID: 31892702 DOI: 10.1038/s41598-019-56013-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
14 Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ 2019;367:l5770. [PMID: 31649096 DOI: 10.1136/bmj.l5770] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 15.5] [Reference Citation Analysis]
15 M. Al-jasser A, Ahmed Al-anazi K. Infections in Patients with Multiple Myeloma in the Era of Novel Agents and Stem Cell Therapies. Update on Multiple Myeloma 2019. [DOI: 10.5772/intechopen.81683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Lewalle P, Pochon C, Michallet M, Turlure P, Brissot E, Paillard C, Puyade M, Roth-Guepin G, Yakoub-Agha I, Chantepie S. [Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer 2019;106:S23-34. [PMID: 30616839 DOI: 10.1016/j.bulcan.2018.08.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
17 Abad CLR, Razonable RR. An update on Mycobacterium tuberculosis infection after hematopoietic stem cell transplantation in adults. Clin Transplant 2018;32:e13430. [PMID: 30347465 DOI: 10.1111/ctr.13430] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
18 Cho SY, Lee HJ, Lee DG. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. Korean J Intern Med 2018;33:256-76. [PMID: 29506345 DOI: 10.3904/kjim.2018.036] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
19 Agrawal N, Aggarwal M, Kapoor J, Ahmed R, Shrestha A, Kaushik M, Bhurani D. Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation. Transpl Infect Dis 2018;20:e12794. [DOI: 10.1111/tid.12794] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]